FDA NDC Directory · JSON-LD · Markdown

UPTRAVI

NDC 66215-718 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, FOR SOLUTION

Generic nameSelexipag
Labeler / ManufacturerActelion Pharmaceuticals US, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA214275
Dosage form / routeINJECTION, POWDER, FOR SOLUTION · INTRAVENOUS
Active ingredientsSELEXIPAG (1800 ug/10mL)
Marketing started20210729
Package count1

External sources

Source: openFDA. Public-domain (CC0).